Treats bacterial vaginosis in females 12 years of age and older. ANDA 216795, held by Encube Ethicals. Metronidazole.
As of Nov 21, 2026, ANDA 216795 (Metronidazole), held by Encube Ethicals, was first approved by FDA on Mar 18, 2024, with 0 approved supplements and 0 published complete response letters.
Metronidazole vaginal gel is indicated for the treatment of bacterial vaginosis in females 12 years of age and older.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 18, 2024 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metronidazole1.3% · gel;vaginal | Metronidazole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters